DATROWAY® (datopotamab deruxtecan-dlnk) demonstrated unprecedented median overall survival ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.
Le Lézard

IMFINZI® (durvalumab) regimen reduced the risk of disease recurrence or death by 32% in ...

Positive results from the POTOMAC Phase III trial showed adding one year of treatment with AstraZeneca's IMFINZI® (durvalumab) to BCG induction and maintenance therapy demonstrated a statistically ...

IMFINZI® (durvalumab)-based regimen reduced the risk of death by 22% in early gastric ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

51-Year-Old Makes Remarkable Recovery With Hybrid TEVAR Surgery After Life-Threatening Torn ...

A 51-year-old man from Kolkata made a miraculous recovery after surviving a torn aorta — one of the most life-threatening ...
BMJ Case Reports

Penetrating aortic ulcer: a rare cause of neck swelling

A woman in her late 80s presented at midnight to the emergency department with sudden onset difficulty breathing, neck pain ...